COVID Intel - by Dr.William Makis

COVID Intel - by Dr.William Makis

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
IVERMECTIN and FENBENDAZOLE Testimonial - Two blood Cancer Cases: Acute Myelogenous Leukemia (AML) patient becomes "cancer free" and Chronic Lymphocytic Leukemia (CLL) patient improves 1st time in 2yr
Copy link
Facebook
Email
Notes
More

IVERMECTIN and FENBENDAZOLE Testimonial - Two blood Cancer Cases: Acute Myelogenous Leukemia (AML) patient becomes "cancer free" and Chronic Lymphocytic Leukemia (CLL) patient improves 1st time in 2yr

Dr. William Makis MD's avatar
Dr. William Makis MD
Jan 18, 2025
∙ Paid
233

Share this post

COVID Intel - by Dr.William Makis
COVID Intel - by Dr.William Makis
IVERMECTIN and FENBENDAZOLE Testimonial - Two blood Cancer Cases: Acute Myelogenous Leukemia (AML) patient becomes "cancer free" and Chronic Lymphocytic Leukemia (CLL) patient improves 1st time in 2yr
Copy link
Facebook
Email
Notes
More
39
27
Share
Ivermectin and Covid-19: how a cheap antiparasitic became political -  Pharmaceutical Technology

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by Dr.William Makis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Dr. William Makis MD
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More